Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397872
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-07
First Post:
2024-04-30
Brief Title:
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Multiple Oral Doses 6 Days of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function
Sponsor:
Madrigal Pharmaceuticals Inc
Organization:
Madrigal Pharmaceuticals Inc
Organization Data
Organization:
Madrigal Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
MGL-3196-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Madrigal Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None